Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis

Transfusion and Apheresis Science

Volumn 49, Issue 2, 2013, Pages 268-277

  Dann, Eldad J ^a,e   Shamir, Raanan ^b,f   Mashiach, Tatiana ^a   Shaoul, Ron ^b,e   Badian, Alla ^a   Stravets, Tselestina ^a   Kerzman, Yelena ^a   Finkelbaum, Svetlana ^a   Gaitini, Diana ^c,e   Lorber, Avraham ^d,e   Bonstein, Lilach ^a,e  

^a Blood Bank and Apheresis Unit   (Israel)

^b Clalit HMO   (Israel)

^c Israel Institute of Technology ^*  (Israel)

^d Rambam Health Care Campus   (Israel)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^f SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Children; Familial hypercholesterolemia; LDL apheresis; Plasmapheresis

Indexed keywords

ATORVASTATIN; CHOLESTEROL; EZETIMIBE PLUS ROSUVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; AORTA VALVE; APHERESIS; ARTERIAL WALL THICKNESS; ARTICLE; CENTRAL VENOUS CATHETER; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DOPPLER ECHOCARDIOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; IRON DEFICIENCY ANEMIA; LOW DENSITY LIPOPROTEIN APHARESIS; MEDICAL RECORD REVIEW; PLASMAPHERESIS; RETROSPECTIVE STUDY; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND TRANSDUCER;

CHILDREN; FAMILIAL HYPERCHOLESTEROLEMIA; LDL-APHERESIS; PLASMAPHERESIS;

ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; MALE; PLASMAPHERESIS;

EID: 84886639665     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.05.001     Document Type: Article

References (21)

1. Jensen H.K. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Dan Med Bull 2002, 49:318-345.
2. Raal F.J., Pilcher G.J., Panz V.R., van Deventer H.E., Brice B.C., Blom D.J., et al. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Circulation 2011, 124:2202-2207.
3. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The metabolic and molecular bases of inherited disease 2001, 2863-2913. McGraw-Hill, Inc., New York. 8th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
4. Tonstad S., Thompson G.R. Management of hyperlipidemia in the pediatric population. Curr Treat Options Cardiovasc Med 2004, 6:431-437.
5. Cohen H., Stein-Zamir C., Hamiel O., Lebenthal Y., Schurr D., Harats D., et al. Israeli guidelines for the management of hypercholesterolemia in children and adolescents. Report of the pediatric association expert group. E Spen Eur E J Clin Nutr Metab 2010, 5:e132-e143.
6. Zhou M., Wu L., Liang J., Shen C., Lin J. Expression analysis and functional characterization of a novel cold-responsive gene CbCOR15a from Capsella bursa-pastoris. Mol Biol Rep 2012, 39:5169-5179.
7. Snozek C.L., Lagerstedt S.A., Khoo T.K., Rubenfire M., Isley W.L., Train L.J., et al. LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance. Eur J Hum Genet 2009, 17:85-90.
8. Thompson G.R. Recommendations for the use of LDL apheresis. Atherosclerosis 2008, 198:247-255.
9. Reshef A., Nissen H., Triger L., Hensen T.S., Eliav O., Schurr D., et al. Molecular genetics of familial hypercholesterolemia in Israel. Hum Genet 1996, 98:581-586.
10. Rifai N., Wamkk G.R. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. Tietz textbook of clinical chemistry and molecular diagnostics 2006, 903-943. Elsevier Saunders, St. Louis. C.A. Burns, E.R. Ashwood, D.E. Brans (Eds.).
11. Nauck M., Warnick G.R., Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002, 48:236-254.
12. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
13. Hudgins L.C., Kleinman B., Scheuer A., White S., Gordon B.R. Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia. Am J Cardiol 2008, 102:1199-1204.
14. Kroon A.A., Aengevaeren W.R., van der Werf T., Uijen G.J., Reiber J.H., Bruschke A.V., et al. LDL-apheresis atherosclerosis regression study (LAARS): effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996, 93:1826-1835.
15. Thompson G.R., Lowenthal R., Myant N.B. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1975, 1:1208-1211.
16. Palcoux J.B., Atassi-Dumont M., Lefevre P., Hequet O., Schlienger J.L., Brignon P., et al. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21years. Ther Apher Dial 2008, 12:195-201.
17. Stefanutti C., Lanti A., Di Giacomo S., Mareri M., De Lorenzo F., Landolfo A., et al. Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks. Transfus Apher Sci 2004, 31:3-10.
18. Stefanutti C., Di Giacomo S., Vivenzio A., Colloridi V., Bosco G., Berni A., et al. Low-density lipoprotein apheresis in a patient aged 3.5years. Acta Paediatr 2001, 90:694-701.
19. Coker M., Ucar S.K., Simsek D.G., Darcan S., Bak M., Can S. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia. Ther Apher Dial 2009, 13:121-128.
20. Koga N., Iwata Y. Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia. Atherosclerosis 1991, 90:9-21.
21. Matsuzaki M., Hiramori K., Imaizumi T., Kitabatake A., Hishida H., Nomura M., et al. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the low density lipoprotein-apheresis coronary morphology and reserve trial (LACMART). J Am Coll Cardiol 2002, 40:220-227.